Prevalence of Food Allergies in a Cohort of Adult Patients With Eosinophilic Esophagitis
EE
1 other identifier
observational
31
1 country
1
Brief Summary
Eosinophilic esophagitis is characterized by an eosinophilic infiltration of the esophagus. It presents clinically with a variety of symptoms including dysphagia, emesis, and food impaction. Although the underlying mechanism is different, gastroesophageal reflux can present with similar clinical findings but can be distinguished from eosinophilic esophagitis by the number of eosinophils present on esophageal biopsy. In children, food allergies play a role in exacerbating eosinophilic esophagitis, but the role of food allergies in adults is uncertain. In this study, we aim to determine the prevalence of food allergies in a cohort of adults with eosinophilic esophagitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 27, 2012
CompletedFirst Posted
Study publicly available on registry
June 29, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedJuly 10, 2018
July 1, 2018
3.2 years
June 27, 2012
July 6, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of food allergies in a cohort of adult patients with EE.
Study to close on or around May 2014
Study Arms (2)
eosinophilic esophagitis
PATIENTS WITH A CURRENT DIAGNOSIS OF eosinophilic esophagitis.
GERD
PATIENTS WITH A DIAGNOSIS WITH GERD.
Eligibility Criteria
Male and female subjects, ages 18 years and older with findings of \> 15 eosinophils per high powered field by endoscopic esophageal biopsy. Patients should also have symptoms consistent with eosinophilic esophagitis including dysphagia, heartburn, epigastric pain, recurrent vomiting, or food impaction. The comparative group will include male and female subjects, ages 18 years and older with a previous diagnosis of gastroesophageal reflux with findings of \< 15 eosinophils per high power field by endoscopic esophageal biopsy.
You may qualify if:
- Male and female subjects 18 years and older
- Previous diagnosis of eosinophilic esophagitis with clinical symptoms including heartburn, dysphagia, vomiting, epigastric pain, recurrent vomiting, food impaction as well \> 15 eosinophils per high powered field (400x magnification) by endoscopic esophageal biopsy in both the proximal and distal esophagus
- Previous diagnosis of gastroesophageal reflux with \< 15 eosinophils per high powered field (400x magnification) by endoscopic biopsy
You may not qualify if:
- \. Male and female subjects less than 18 years of age 2. Pregnant female subjects 3. Subjects who are receiving systemic steroids and are unable to stop prior to enrollment 4. Subjects who are receiving systemic antihistamines and are unable to stop prior to enrollment 5. Subjects who are unable to cooperate/comply with study procedures or communicate with investigator in order to successfully complete the study 6. Subjects with severe skin disorders such as atopic dermatitis, dermatographism, or psoriasis who would be unable to complete skin or patch testing 7. Subjects with an infirmity, disability, or geographical location which seems likely to prevent regular attendance for patient visit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of South Florida
Tampa, Florida, 33613, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Division Director, Prinicpal Investogator
Study Record Dates
First Submitted
June 27, 2012
First Posted
June 29, 2012
Study Start
May 1, 2011
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
July 10, 2018
Record last verified: 2018-07